Newsletter | September 11, 2026

09.11.26 -- The Supply Chain Stress Test Every Sponsor Should Take

SPONSOR

 

Unlocking Challenging Targets with Macrocycle DNA-Encoded Libraries

What if the next breakthrough target requires more than a conventional small molecule? Explore how macrocycle DNA-encoded libraries are opening new paths to challenging drug targets. This X-CHEM webinar will reveal how macrocycles expand chemical space, uncover differentiated hits, and generate insights that can accelerate discovery. Learn where macrocycle DELs can make the biggest impact and how they could reshape your strategy. Click here to learn more.

INDUSTRY INSIGHTS

 

Powering Drug Development With Advanced AI Retrosynthetic Analysis Tools

Review advanced retrosynthetic analysis services and how these tools empower better, more efficient development of innovative small molecule drugs.

 

Realizing The Potential Of The Evolving CDMO Ecosystem

Pharma is shifting to integrated manufacturing partners to handle complex drugs. Technical synergy and global alignment boost resilience and speed patient access.

 

Open-Label Study Assessing Relative And Absolute Bioavailability

Consistent absorption across different formulations and dietary conditions ensures stable therapeutic exposure. This flexibility simplifies patient dosing schedules and supports manufacturing transitions.

FEATURED EDITORIAL

Effective Sponsor–CDMO Collaboration And Communication

Effective sponsor–CDMO collaboration relies on clear communication, shared expectations, and proactive problem-solving. In this episode, guest panelists Stella Vnook, Co-founder and Executive Board Chair, Kaida BioPharma, and Allison Vavala, Senior Director for Business Development, Flamma Group, explore what makes these operating relationships work. The discussion covers building strong day-to-day partnerships, establishing practical meeting cadences, and setting transparent goals from the start.

 

The Supply Chain Stress Test Every Sponsor Should Take

For sponsors rethinking China-exposed supply chains, BIOSECURE is less a warning label than a stress test for redundancy, oversight, data control, and operational resilience.

INDUSTRY INSIGHTS CONTINUED

 

Performance Through Process Understanding In ASD Scale- Up

Explore the formulation and manufacturing considerations for amorphous solid dispersions (ASDs), with a focus on hot melt extrusion (HME) as a scalable and cost-effective technology option.

 

6 Strategic Pillars For Selecting A Drug Packaging Partner

Early engagement with an expert packaging partner supports safe, cost-effective drug development and logistical success from precommercial stages through full market launch.

 

From Compressed Timelines To AI: The Forces Redefining CDMO Success

Gain practical perspective on emerging capabilities, common sponsor challenges, and what will matter most as the CDMO landscape continues to evolve.

 

Meeting Modern Challenges With A Next Generation Solution

Ophthalmic injectable packaging demands strategic attention. Learn how silicone oil contamination, particulate limits, and dosing accuracy challenges can derail development programs.

SOLUTIONS

Tailored CDMO And Clinical Supply Solutions For Complex Needs

Solvent-Free, Fusion-Based Amorphic Dispersion Process

Process Development And Preclinical Manufacturing — India

OUTSOURCED PHARMA CAPABILITIES UPDATE

Find Your New CDMO At Outsourced Pharma Capabilities Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

 

Connect With Outsourced Pharma: